DyeVert™ PLUS

Taking Kidney Care to Heart

Revolutionary contrast reduction,
uncompromised imaging.

Have a Heart, Be Kind to Kidneys™

At Osprey Medical, our mission is to improve outcomes in patients with Chronic Kidney Disease by reducing contrast induced Acute Kidney Injury (AKI) and lowering hospital costs. Osprey’s proprietary technologies reduce the amount of contrast (dye) injected into patients during heart catheterization procedures without compromising X-ray image quality for the physician.

Learn more

We are Osprey Medical

Our vision is to make angiography safer for CKD patients.

Kidney Care – Reducing AKI in the Cath Lab

Kidney Care is about reducing AKI in the Cath Lab

Clinical Guidelines outline Kidney Care Protocols

Learn more

Uncompromised Dye Reduction

The only FDA indicated technology for reducing dye dosage to patients

Watch the video

DyeVert™ PLUS. Taking Kidney Care to Heart.

See the revolutionary technology indicated to reduce harmful contrast (dye) dosage delivered to patients.

Learn more

Watch the video

Osprey Medical and GE Healthcare Launch New Educational Program to Increase Awareness of Strategies to Help Address Acute Kidney Injury (AKI)

September 20, 2018

Osprey Medical (ASX:OSP) is pleased to announce a collaboration with GE Healthcare on Osprey’s Be Kind to Kidneys™ campaign. The campaign aims to increase awareness of strategies to help address acute kidney injury (AKI) following normal heart imaging procedures (angiograms) in patients with chronic kidney disease (CKD). As part of the campaign, Osprey Medical and GE Healthcare will sponsor a number of educational programs and seminars for healthcare professionals on how to address the risk of AKI.

Cutting Down on Dye May Make Heart Procedures Safer for Kidney Patients

June 8, 2017

San Antonio's University Hospital is one of the first hospitals to use a device called DyeVert Plus. Bluetooth technology embedded in the syringe uses wireless transmission to track exactly how much dye is used for each image. Tests of the new device show it can reduce the amount of dye used in heart procedures on kidney patients by as much as 40 percent.

Photo credit (Kidney Care): Blausen.com staff (2014). “Medical gallery of Blausen Medical 2014“. WikiJournal of Medicine 1 (2). DOI:10.15347/wjm/2014.010. ISSN 2002-4436.